CytoDyn completes $14.5 million private placement
CytoDyn has raised $14.5 million in a private placement. Paulson Investment Company acted as the placement agent. Based in Vancouver, Wash., CytoDyn is a biotech company focused on combating infection with immune deficiency viruses.
25 October 2013•3 mins read
